Hanneke Schuitemaker mainly investigates Virology, Immunology, Virus, Antibody and Viral disease. Her studies in Virology integrate themes in fields like Epitope, T cell and Peripheral blood mononuclear cell. Her Immunology research integrates issues from Cytotoxic T cell and Acquired immunodeficiency syndrome.
Her studies deal with areas such as Phenotype, Humoral immunity, CXCR4 and Monocyte as well as Virus. Hanneke Schuitemaker combines subjects such as Protein structure and Glycosylation with her study of Antibody. Hanneke Schuitemaker works mostly in the field of Viral disease, limiting it down to topics relating to Immunopathology and, in certain cases, Sida.
Her primary scientific interests are in Virology, Immunology, Virus, Antibody and Viral load. In her study, which falls under the umbrella issue of Virology, Viral vector is strongly linked to Immune system. Her study connects Acquired immunodeficiency syndrome and Immunology.
The study incorporates disciplines such as Phenotype, Cell culture, Peripheral blood mononuclear cell and In vivo in addition to Virus. Her Antibody research is multidisciplinary, relying on both Glycosylation and Glycoprotein. The Viral load study which covers Human leukocyte antigen that intersects with CTL* and Allele.
Her scientific interests lie mostly in Virology, Immunogenicity, Immunology, Antibody and Vaccination. Her Virology study frequently draws connections to adjacent fields such as Viral vector. Her work deals with themes such as Neutralizing antibody, Regimen, Immunization, Humoral immunity and Coronavirus, which intersect with Immunogenicity.
When carried out as part of a general Immunology research project, her work on Viral load, Influenza vaccine and Broadly neutralizing antibody is frequently linked to work in Double blind, therefore connecting diverse disciplines of study. Her Antibody research is multidisciplinary, incorporating perspectives in Protein structure, Glycosylation and Immune system. She has included themes like Potency, Respiratory Syncytial Virus Vaccines and Heterologous in her Virus study.
Virology, Antibody, Immunogenicity, Immunity and Immunology are her primary areas of study. Hanneke Schuitemaker works on Virology which deals in particular with Virus. Her work carried out in the field of Antibody brings together such families of science as Protein structure, Viral vector and Antigen.
Her work in Immunogenicity addresses issues such as Vaccination, which are connected to fields such as Adverse effect, Seroconversion and Reactogenicity. Her Immunity study combines topics in areas such as Neutralizing antibody and Immunization. Her Immunology study focuses on Viral load in particular.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population.
H Schuitemaker;M Koot;N A Kootstra;M W Dercksen.
Journal of Virology (1992)
A new classification for HIV-1
E. A. Berger;R. W. Doms;E.-M. Fenyö;B. T. M. Korber.
Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule.
R A Fouchier;M Groenink;N A Kootstra;M Tersmette.
Journal of Virology (1992)
Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics.
M R Klein;C A van Baalen;A M Holwerda;S R Kerkhof Garde.
Journal of Experimental Medicine (1995)
T cell depletion in HIV-1 infection: how CD4+ T cells go out of stock.
Mette D. Hazenberg;Dörte Hamann;Hanneke Schuitemaker;Frank Miedema.
Nature Immunology (2000)
Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies.
Hugo Mouquet;Louise Scharf;Zelda Euler;Yan Liu.
Proceedings of the National Academy of Sciences of the United States of America (2012)
Monocytotropic human immunodeficiency virus type 1 (HIV-1) variants detectable in all stages of HIV-1 infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture.
H. Schuitemaker;N. A. Kootstra;R. E. Y. De Goede;F. De Wolf.
Journal of Virology (1991)
Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques.
Noe B. Mercado;Roland Zahn;Frank Wegmann;Carolin Loos;Carolin Loos.
T-cell dysfunction in HIV infection: anergy due to defective antigen-presenting cell function?
Linde Meyaard;Hanneke Schuitemaker;Frank Miedema.
Immunology Today (1993)
Proliferation-dependent HIV-1 infection of monocytes occurs during differentiation into macrophages.
Hanneke Schuitemaker;Neeltje A. Kootstra;Marco H. G. M. Koppelman;Sylvia M. Bruisten.
Journal of Clinical Investigation (1992)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: